Background: Anti-vascular endothelial growth factor (VEGF) therapy is currently the most effective therapy of exudative age-related macular degeneration (AMD). The aim of this study was to assess long-term benefits of intensive aflibercept and ranibizumab anti-VEGF therapy in patients with exudative AMD.
Methods: Two clinical trial sites recruited their original subjects for a re-evaluation 7 years after the baseline visit of the phase-3 Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (VIEW 2) trial.
Background: This study aimed to determine the relationship between image quality and measurement repeatability of optical coherence tomography angiography (OCTA) parameters in patients with non-proliferative diabetic retinopathy.
Methods: A total of 100 eyes of 50 patients were included in the study. Three OCTA images were obtained consecutively during one session of imaging in all patients using the RTVue AngioVue OCTA device.
Introduction: Optical coherence tomography angiography is a non-invasive imaging technique that is able to visualize the different retinal vascular layers using motion contrast to detect blood flow without intravenous dye injection. This method might help to assess microangiopathy in diabetic retinopathy during screening and follow-up.
Aim: To quantify retinal microvasculature alterations in both eyes of diabetic patients in relation to systemic risk factors using optical coherence tomography angiography.
Introduction And Aim: The correction of aphakia might be a challenge for the surgeon. The aim of this study is to describe the authors' experience with the implantation of the retropupillary iris clip intraocular lens.
Method: Patients between January 2014 and December 2015 were included in the retrospective study.
Introduction: Vascular endothelial growth factor antibody therapy is an established treatment of exsudative age-related macular degeneration.
Aim: The morphologic characterisation of the macular microvasculature after longstanding treatment.
Method: Forty-eight patients (34 women and 14 men; age, 74.
Introduction: The results of intravitreal ranibizumab treatment for exsudative age-related macular degeneration have been favourable until this time.
Aim: To evaluate the two-year functional and anatomic results of intravitreal ranibizumab treatment.
Method: 46 patients (age: 75 ± 9.